tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SPRO Stock Latest News

GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
Company AnnouncementsGSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
7d ago
8K
SPRO
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
PremiumThe Fly
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
7d ago
GSK
SPRO
Spero Therapeutics announces inducement grant under Nasdaq listing rule
PremiumThe Fly
Spero Therapeutics announces inducement grant under Nasdaq listing rule
28d ago
SPRO
Spero Therapeutics Focuses on Tebipenem HBr Program
PremiumCompany Announcements
Spero Therapeutics Focuses on Tebipenem HBr Program
1M ago
SPRO
Spero Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Spero Therapeutics Reports Q3 2025 Financial Results
1M ago
8K
SPRO
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
PremiumThe FlySpero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
2M ago
GSK
SPRO
Spero Therapeutics’ Positive Earnings Call Highlights
Premium
Company Announcements
Spero Therapeutics’ Positive Earnings Call Highlights
4M ago
SPRO
Spero Therapeutics Reports Q2 2025 Results and Trial Success
Premium
Company Announcements
Spero Therapeutics Reports Q2 2025 Results and Trial Success
5M ago
SPRO
Spero Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Spero Therapeutics Reports Q2 2025 Financial Results
5M ago
8K
SPRO
GSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
PremiumCompany Announcements
GSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
6M ago
GSK
SPRO
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
PremiumCompany Announcements
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
6M ago
GSK
SPRO
Spero Therapeutics Increases Stock Incentive Plan Shares
PremiumCompany Announcements
Spero Therapeutics Increases Stock Incentive Plan Shares
6M ago
8K
SPRO
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
7M ago
NNE
RKT
3 Penny Stocks to Watch Now, 5/29/25
Premium
Market News
3 Penny Stocks to Watch Now, 5/29/25
7M ago
SGN
SPRO
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data
Premium
Market News
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data
7M ago
GSK
SPRO
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
PremiumMarket News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
7M ago
M
KO
Spero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
PremiumCompany Announcements
Spero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
7M ago
8K
SPRO
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
PremiumThe Fly
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
7M ago
GSK
SPRO
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
PremiumThe Fly
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
7M ago
GSK
SPRO
Spero Therapeutics Reports Q1 2025 Results and Updates
PremiumCompany AnnouncementsSpero Therapeutics Reports Q1 2025 Results and Updates
8M ago
SPRO
Spero Therapeutics Appoints New CEO Esther Rajavelu
Premium
Company Announcements
Spero Therapeutics Appoints New CEO Esther Rajavelu
8M ago
8K
SPRO
Spero Therapeutics appoints Esther Rajavelu will serve as CEO
Premium
The Fly
Spero Therapeutics appoints Esther Rajavelu will serve as CEO
8M ago
SPRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >